Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1951 1
1980 1
1981 3
1987 1
1990 1
1992 1
2012 1
2013 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and tolerance of betamethasone dipropionate propylene glycol for resistant psoriasis and other resistant steroid-responsive dermatoses.
Gutierrez Aldana G. Gutierrez Aldana G. J Int Med Res. 1981;9(6):448-52. doi: 10.1177/030006058100900605. J Int Med Res. 1981. PMID: 7319131
Betamethasone dipropionate, 0.05%, in a propylene glycol ointment vehicle (Diprolene Ointment) was administered to forty-seven patients with resistant psoriasis or other resistant steroid-responsive dermatoses in a 2 week open study. ...
Betamethasone dipropionate, 0.05%, in a propylene glycol ointment vehicle (Diprolene Ointment) was administered to fort …
The effects of increased penetration of betamethasone dipropionate in a propylene glycol base (Diprolene) for psoriasis.
Kansky A. Kansky A. J Int Med Res. 1981;9(2):128-31. doi: 10.1177/030006058100900208. J Int Med Res. 1981. PMID: 7227624
The efficacy and safety of betamethasone dipropionate, 0.05% in a propylene glycol base (Diprolene), was investigated in an open, fixed-dose study of thirty-one patients with resistant psoriasis. ...
The efficacy and safety of betamethasone dipropionate, 0.05% in a propylene glycol base (Diprolene), was investigated i …
In vitro effect of beclomethasone dipropionate and flunisolide on the mobility of human nasal cilia.
Stafanger G. Stafanger G. Allergy. 1987 Oct;42(7):507-11. doi: 10.1111/j.1398-9995.1987.tb00373.x. Allergy. 1987. PMID: 3688375 Clinical Trial.
Human nasal cilia were perfused with aqueous solutions of two corticosteroid aerosols, beclomethasone dipropionate (BPD) and flunisolide, with the main preservative of flunisolide, propylene glycol, and with placebo. The concentration used were BPD 0.1 mg/ml, …
Human nasal cilia were perfused with aqueous solutions of two corticosteroid aerosols, beclomethasone dipropionate (BPD) and flunisol …
Fabrication, characterization and optimization of nanostructured lipid carrier formulations using Beclomethasone dipropionate for pulmonary drug delivery via medical nebulizers.
Khan I, Hussein S, Houacine C, Khan Sadozai S, Islam Y, Bnyan R, Elhissi A, Yousaf S. Khan I, et al. Int J Pharm. 2021 Apr 1;598:120376. doi: 10.1016/j.ijpharm.2021.120376. Epub 2021 Feb 20. Int J Pharm. 2021. PMID: 33617949
Novel composition and combination of NLC formulations (F1 - F15) were prepared via ultrasonication method, employing five solid lipids (glycerol trimyristate (GTM), glycerol trilaurate (GTL), cetyl palmitate (CP), glycerol monostearate (GMS) and stearic acid (SA)); and three liqu …
Novel composition and combination of NLC formulations (F1 - F15) were prepared via ultrasonication method, employing five solid lipids (glyc …
Topical corticosteroids and Staphylococcus aureus in atopic dermatitis.
Nilsson EJ, Henning CG, Magnusson J. Nilsson EJ, et al. J Am Acad Dermatol. 1992 Jul;27(1):29-34. doi: 10.1016/0190-9622(92)70151-5. J Am Acad Dermatol. 1992. PMID: 1619073 Clinical Trial.
S. aureus was eliminated after a successful 2-week treatment with a very potent corticosteroid. Propylene glycol 25% added to a moderately potent corticosteroid did not significantly increase the reduction of S. aureus. ...
S. aureus was eliminated after a successful 2-week treatment with a very potent corticosteroid. Propylene glycol 25% added to …
Liposome encapsulation improves efficacy of betamethasone dipropionate in atopic eczema but not in psoriasis vulgaris.
Korting HC, Zienicke H, Schäfer-Korting M, Braun-Falco O. Korting HC, et al. Eur J Clin Pharmacol. 1990;39(4):349-51. doi: 10.1007/BF00315408. Eur J Clin Pharmacol. 1990. PMID: 2076716 Clinical Trial.
The effect of a liposomal preparation of beta-methasone dipropionate (0.039%, BDP) has been compared to that of a commercial propylene glycol-gel containing 0.064% BDP in a double-blind, randomized, paired trial lasting 14 d in 10 patients with atopic eczema …
The effect of a liposomal preparation of beta-methasone dipropionate (0.039%, BDP) has been compared to that of a commercial propy
[Pustular psoriasis localized to the genital region].
Dauendorffer JN, Bagot M, Bachelez H, Cavelier-Balloy B. Dauendorffer JN, et al. Ann Dermatol Venereol. 2013 May;140(5):386-7. doi: 10.1016/j.annder.2013.02.017. Epub 2013 Mar 27. Ann Dermatol Venereol. 2013. PMID: 23663713 French. No abstract available.
Efficacy of a betamethasone dipropionate topical glycol preparation in the management of severe psoriasis.
Leer JA Jr. Leer JA Jr. Clin Ther. 1980;3(3):156-67. Clin Ther. 1980. PMID: 7006810 Clinical Trial.
A multicenter, double-blind clinical evaluation of three formulations of betamethasone dipropionate was conducted in 258 patients with severe psoriasis. The results obtained after a standard two-week treatment period clearly indicated that a new glycol preparation p …
A multicenter, double-blind clinical evaluation of three formulations of betamethasone dipropionate was conducted in 258 patients wit …
12 results